Pan-cancer tumor classification by a holistic tumor microenvironment atlas
Qin, S.; Xiao, D.; Li, J.; Nan, J.; Diao, T.; Bo, Y.; Gao, Q.; Zheng, L.; Ling, X.; Gao, Q.; Li, X.; Gao, S.; Tang, F.; Zhang, W.; Li, C.; Fang, P.; Zhu, L.; Wang, D.; Zhang, Z.
Show abstract
The tumor microenvironment (TME) heterogeneity presents a major bottleneck to effective cancer immunotherapies. We address this by establishing a pan-cancer tumor classification system based on the holistic TME cellular components. First, using single-cell transcriptomes from 1,271 patients across 26 cancer types, we compile a TME cellular atlas, leading to the identification of recurrent cell states and multicellular modules across cancer types. Among these, we highlight a type I interferon (IFN-I)-related multicellular module, including IFIT1+ tumor-associated macrophages, as a critical contributor to immune-activation TMEs. From a holistic perspective, pan-cancer TMEs exhibit trichotomous patterns predominantly driven by T, myeloid, and stromal compartments. Leveraging fine-grained TME cellular composition, we further stratify all tumors into 10 stable groups. These groups display varying responses to immune checkpoint blockade (ICB), and each rationally selected therapeutic strategy specifically perturbs the corresponding expression signature. Our pan-cancer tumor classification scheme reveals the underlying patterns of TME heterogeneity and provides a framework for stratifying patients, guiding treatment selection, and developing novel therapeutic options.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Projecting single-cell transcriptomics data onto a reference T cell atlas to interpret immune responses 98%
- MetaTiME: Meta-components of the Tumor Immune Microenvironment 98%
- Integration of scHi-C and scRNA-seq data defines distinct 3D-regulated and biological-context dependent cell subpopulations 97%
Similar papers in this journal
- Modulating immune cell fate and inflammation through CRISPR-mediated DNA methylation editing 96%
- Charting the transcriptomic landscape of primary and metastatic cancers in relation to their origin and target normal tissues 96%
- 1-Methylnicotinamide is an immune regulatory metabolite in human ovarian cancer 96%
Similar papers in this journal
- Cell transcriptomic atlas of the non-human primate Macaca fascicularis 97%
- An integrated transcriptomic and epigenomic atlas of mouse primary motor cortex cell types 97%
- A human DNA methylation atlas reveals principles of cell type-specific methylation and identifies thousands of cell type-specific regulatory elements 97%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.